Aileron Therapeutics Stock (NASDAQ: ALRN) stock price, news, charts, stock research, profile.
Open | $3.71 |
Close | - |
Volume / Avg. | 15.60K / 82.87K |
Day Range | $3.52 - $3.71 |
52 Wk Range | 1.01 - 7.42 |
Market Cap | $83.20M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 71 |
Short Interest | 1.37% |
Days to Cover | 7.21 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Aileron Therapeutics (NASDAQ:ALRN) through any online brokerage.
Other companies in Aileron Therapeutics’s space includes: Renovaro (NASDAQ:RENB), Serina Therapeutics (AMEX:SER), Cellectar Biosciences (NASDAQ:CLRB), Immuneering (NASDAQ:IMRX) and Armata Pharmaceuticals (AMEX:ARMP).
Aileron Therapeutics has a consensus price target of $10.00.
The stock price for Aileron Therapeutics (NASDAQ: ALRN) is $3.68 last updated September 24, 2024 at 10:37 AM EDT.
There are no upcoming dividends for Aileron Therapeutics.
Aileron Therapeutics’s Q3 earnings are confirmed for Friday, October 11, 2024.
There is no upcoming split for Aileron Therapeutics.
Aileron Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.